Vectus Biosystems Ltd

VBS

Company Profile

  • Business description

    Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including cardio, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.

  • Contact

    26-34 Dunning Avenue
    Unit 5, Ground Floor
    Rosebery
    SydneyNSW2018
    AUS

    T: +61 283441300

    https://www.vectusbiosystems.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

Stocks News & Analysis

stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.
stocks

Investor Playbook: Can your portfolio handle what’s next?

Testing portfolio resilience in an uncertain market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,187.2017.30-0.19%
CAC 408,368.917.550.09%
DAX 4026,749.9521.93-0.08%
Dow JONES (US)52,347.5550.460.10%
FTSE 10010,902.5639.470.36%
HKSE23,835.44197.840.84%
NASDAQ25,136.27229.82-0.91%
Nikkei 22560,042.511,099.84-1.80%
NZX 50 Index14,274.92101.240.71%
S&P 5007,561.6730.73-0.40%
S&P/ASX 2009,066.1016.10-0.18%
SSE Composite Index3,620.0014.35-0.39%

Market Movers